329 related articles for article (PubMed ID: 22230779)
1. Industrial biotransformations in the synthesis of building blocks leading to enantiopure drugs.
Muñoz Solano D; Hoyos P; Hernáiz MJ; Alcántara AR; Sánchez-Montero JM
Bioresour Technol; 2012 Jul; 115():196-207. PubMed ID: 22230779
[TBL] [Abstract][Full Text] [Related]
2. Biocatalysis: synthesis of chiral intermediates for drugs.
Patel RN
Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
[TBL] [Abstract][Full Text] [Related]
3. Biocatalytic strategies for the asymmetric synthesis of alpha-hydroxy ketones.
Hoyos P; Sinisterra JV; Molinari F; Alcántara AR; Domínguez de María P
Acc Chem Res; 2010 Feb; 43(2):288-99. PubMed ID: 19908854
[TBL] [Abstract][Full Text] [Related]
4. Biocatalytic synthesis of enantiopure building blocks for pharmaceuticals.
Simon RC; Mutti FG; Kroutil W
Drug Discov Today Technol; 2013; 10(1):e37-44. PubMed ID: 24050228
[TBL] [Abstract][Full Text] [Related]
5. Advances in biocatalytic synthesis of pharmaceutical intermediates.
Panke S; Wubbolts M
Curr Opin Chem Biol; 2005 Apr; 9(2):188-94. PubMed ID: 15811804
[TBL] [Abstract][Full Text] [Related]
6. The production of fine chemicals by biotransformations.
Straathof AJ; Panke S; Schmid A
Curr Opin Biotechnol; 2002 Dec; 13(6):548-56. PubMed ID: 12482513
[TBL] [Abstract][Full Text] [Related]
7. Microbial/enzymatic synthesis of chiral pharmaceutical intermediates.
Patel RN
Curr Opin Drug Discov Devel; 2003 Nov; 6(6):902-20. PubMed ID: 14758760
[TBL] [Abstract][Full Text] [Related]
8. Biocatalytic routes to chiral amines and amino acids.
Gotor-Fernández V; Gotor V
Curr Opin Drug Discov Devel; 2009 Nov; 12(6):784-97. PubMed ID: 19894190
[TBL] [Abstract][Full Text] [Related]
9. Biocatalysis in development of green pharmaceutical processes.
Tao J; Xu JH
Curr Opin Chem Biol; 2009 Feb; 13(1):43-50. PubMed ID: 19264533
[TBL] [Abstract][Full Text] [Related]
10. Biocatalysis for pharmaceutical intermediates: the future is now.
Pollard DJ; Woodley JM
Trends Biotechnol; 2007 Feb; 25(2):66-73. PubMed ID: 17184862
[TBL] [Abstract][Full Text] [Related]
11. Large-scale oxidations in the pharmaceutical industry.
Caron S; Dugger RW; Ruggeri SG; Ragan JA; Ripin DH
Chem Rev; 2006 Jul; 106(7):2943-89. PubMed ID: 16836305
[No Abstract] [Full Text] [Related]
12. Recent progress in industrial biocatalysis.
Nestl BM; Nebel BA; Hauer B
Curr Opin Chem Biol; 2011 Apr; 15(2):187-93. PubMed ID: 21195018
[TBL] [Abstract][Full Text] [Related]
13. New opportunities for biocatalysis: driving the synthesis of chiral chemicals.
Zheng GW; Xu JH
Curr Opin Biotechnol; 2011 Dec; 22(6):784-92. PubMed ID: 21783357
[TBL] [Abstract][Full Text] [Related]
14. Applied biotransformations in green solvents.
Hernáiz MJ; Alcántara AR; García JI; Sinisterra JV
Chemistry; 2010 Aug; 16(31):9422-37. PubMed ID: 20669193
[TBL] [Abstract][Full Text] [Related]
15. On the development of new biocatalytic processes for practical pharmaceutical synthesis.
Huisman GW; Collier SJ
Curr Opin Chem Biol; 2013 Apr; 17(2):284-92. PubMed ID: 23462589
[TBL] [Abstract][Full Text] [Related]
16. Discovery and utilization of biocatalysts for chiral synthesis: an overview of Chinese scientists' research and development.
Yu HL; Xu JH; Lu WY; Lin GQ
Adv Biochem Eng Biotechnol; 2009; 113():1-31. PubMed ID: 19623477
[TBL] [Abstract][Full Text] [Related]
17. The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds.
Calcaterra A; D'Acquarica I
J Pharm Biomed Anal; 2018 Jan; 147():323-340. PubMed ID: 28942107
[TBL] [Abstract][Full Text] [Related]
18. Exploring the potential of xenobiotic-metabolising enzymes as biocatalysts: evolving designer catalysts from polyfunctional cytochrome P450 enzymes.
Gillam EM
Clin Exp Pharmacol Physiol; 2005 Mar; 32(3):147-52. PubMed ID: 15743395
[TBL] [Abstract][Full Text] [Related]
19. Homochiral drugs: a demanding tendency of the pharmaceutical industry.
Núñez MC; García-Rubiño ME; Conejo-García A; Cruz-López O; Kimatrai M; Gallo MA; Espinosa A; Campos JM
Curr Med Chem; 2009; 16(16):2064-74. PubMed ID: 19519381
[TBL] [Abstract][Full Text] [Related]
20. Scalable enantioselective processes for chiral pharmaceutical intermediates.
Iida T; Mase T
Curr Opin Drug Discov Devel; 2002 Nov; 5(6):834-51. PubMed ID: 12478715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
